MedPath

University of Aarhus

University of Aarhus logo
🇩🇰Denmark
Ownership
Private
Established
1928-09-11
Employees
5K
Market Cap
-
Website
http://www.au.dk

Effects of Growth Hormone and IGF-1 on Anabolic Signals and Stem Cell Recruitment in Human Skeletal Muscle

Not Applicable
Conditions
Growth Hormone Deficiency
Growth Hormone Treatment
Interventions
First Posted Date
2019-03-18
Last Posted Date
2019-09-26
Lead Sponsor
University of Aarhus
Target Recruit Count
12
Registration Number
NCT03878992
Locations
🇩🇰

Department of Endcrinology, Aarhus N, Denmark

A Feasibility Study of Direct Access to an Abdominal ´Yes-No´ Pathway for Primary Care Patients

Not Applicable
Completed
Conditions
Cancer
Primary Health Care
Interventions
Diagnostic Test: Abdominal ´yes-no´ pathway
First Posted Date
2019-03-18
Last Posted Date
2020-04-16
Lead Sponsor
University of Aarhus
Target Recruit Count
27
Registration Number
NCT03878940
Locations
🇩🇰

Silkeborg Regional Hospital, Central Denmark Region, Silkeborg, Denmark

Impact of Congenital Heart Disease on Neurodevelopmental Outcome

Conditions
Heart Defects, Congenital
Interventions
Other: Magnetic Resonance Imaging
Other: Neuropsychological assessment
First Posted Date
2019-03-12
Last Posted Date
2021-05-10
Lead Sponsor
University of Aarhus
Target Recruit Count
120
Registration Number
NCT03871881
Locations
🇩🇰

Aarhus University Hospital, Aarhus N, Denmark

The Antidepressant Effect of Right Prefrontal Low Frequency rTMS in an Accelerated Treatment Model

Not Applicable
Withdrawn
Conditions
Depression
Interventions
Procedure: repetitive transcranial magnetic stimulation
First Posted Date
2019-03-11
Last Posted Date
2019-08-19
Lead Sponsor
University of Aarhus
Registration Number
NCT03868774

Shared Decision-Making and Dialysis Choice

Not Applicable
Completed
Conditions
Chronic Kidney Diseases
Interventions
Other: SDM-DC
First Posted Date
2019-03-11
Last Posted Date
2019-03-13
Lead Sponsor
University of Aarhus
Target Recruit Count
402
Registration Number
NCT03868800

Metabolic Effects of Melatonin Treatment

Phase 1
Completed
Conditions
Metabolic Disease
Insulin Sensitivity
Glucose Metabolism Disorders (Including Diabetes Mellitus)
Type 2 Diabetes Mellitus
Blood Pressure
Inflammation
Interventions
Drug: Placebo Oral Tablet
Drug: Melatonin
First Posted Date
2019-03-01
Last Posted Date
2021-08-25
Lead Sponsor
University of Aarhus
Target Recruit Count
17
Registration Number
NCT03859934
Locations
🇩🇰

Medical Research Laboratory, Aarhus, Denmark

Low Dose Catheter Directed Thrombolysis for Acute Pulmonary Embolism

Phase 2
Conditions
Pulmonary Embolism
Interventions
First Posted Date
2019-02-26
Last Posted Date
2021-04-28
Lead Sponsor
University of Aarhus
Target Recruit Count
60
Registration Number
NCT03854266
Locations
🇩🇰

Aarhus University Hospital, Dep. Cardiology, Aarhus N, Denmark

Exploring the Comorbidity Between Mental Disorders and General Medical Conditions

Completed
Conditions
Schizophrenia
Neurotic, Stress-related and Somatoform Disorders
Disorders of Adult Personality and Behavior
Behavioural Disorder
Atrial Fibrillation
Heart Failure
Thyroid Disorder
Diverticular Disease of Large Intestine
Osteoporosis
Vision Disorders
Interventions
Other: Organic Disorders
Other: Substance Use Disorders
Other: Schizophrenia Disorders
Other: Mood disorders
Other: Neurotic disorders
Other: Eating Disorders
Other: Personality Disorders
Other: Intellectual Disorders
Other: Developmental Disorders
Other: Behavioral Disorders
First Posted Date
2019-02-20
Last Posted Date
2020-05-22
Lead Sponsor
University of Aarhus
Target Recruit Count
5940299
Registration Number
NCT03847753

Follow-up Using Patient-Reported Outcome (PRO) Measures in Patients With Chronic Kidney Disease

Not Applicable
Completed
Conditions
Chronic Kidney Diseases
Interventions
Behavioral: PRO-based follow-up
Behavioral: PRO-based telephone consultation
First Posted Date
2019-02-20
Last Posted Date
2023-12-22
Lead Sponsor
University of Aarhus
Target Recruit Count
152
Registration Number
NCT03847766
Locations
🇩🇰

Birgith Engelst Grove, Herning, Denmark

Combining TLR9 Agonist With bNAbs for Reservoir Reduction and Immunological Control of HIV

Phase 2
Completed
Conditions
HIV-1-infection
Interventions
Drug: Saline
Drug: Lefitolimod
Drug: 3BNC117 and 10-1074
First Posted Date
2019-02-12
Last Posted Date
2023-05-23
Lead Sponsor
University of Aarhus
Target Recruit Count
47
Registration Number
NCT03837756
Locations
🇩🇰

Dept. of Infectious Diseases, Aalborg University Hospital, Aalborg, Denmark

🇩🇰

Dept. of Infectious Diseases, Odense University Hospital, Odense, Denmark

🇳🇴

Oslo University Hospital, Oslo, Norway

and more 5 locations
© Copyright 2025. All Rights Reserved by MedPath